MutualFundWire.com
The insiders' edge for 40 Act industry executives!
an InvestmentWires' Publication
an InvestmentWires' Publication
|
|
MutualFundWire.com
The insiders' edge for 40 Act industry executives!
an InvestmentWires' Publication |
|
Friday, February 22, 2002 MS Readies Biotech Fund Morgan Stanley Invest Advisors has filed plans with the SEC for a biotechnology fund. The proposed Morgan Stanley Biotechnology Fund will sport A, B, C and D class shares and be managed by the manager's Sector Funds Equity team, including Peter Dannenbaum and Alexander Denner. Printed from: MFWire.com/story.asp?s=1932 Copyright 2002, InvestmentWires, Inc. All Rights Reserved |